For example, genome-wide association studies have identified three genes that are associated with an increased risk of developing AD, CLU (clusterin), CR1 (complement receptor 1), and TREM2 (triggering receptor expressed on myeloid cells 2) [34]. This evidence concerns the gene TREM2 and Alzheimer disease.